EIS — iShares MSCI Israel ETF

EIS Price Performance — Growth of $10,000

Value of a $10,000 investment in EIS over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.

EIS Drawdown

The "underwater" chart: EIS's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.

Overview

The iShares MSCI Israel ETF (EIS) is a Single Country - Developed fund issued by iShares with $874 million in assets under management. It holds a B grade, ranking 8th out of 18 peers in its category and 137th of 458 tracked ETFs overall. The fund charges an expense ratio of 0.59%, which is higher than the category median of 0.5%. Its dividend yield of 1.55% trails the category median of 3.49%. The top ten holdings comprise 54.0% of assets, with the largest position being TEVA PHARMACEUTICAL INDUSTRIES LIMITED at 10.2%.

The ETF was upgraded from a C to a B grade on 2026-10-16, reflecting its current standing. Price history is available for only 3.0 years, limiting the depth of historical context. The fund has delivered a 1-year return of +23.80%, outperforming the category median of +15.82%. However, the 6-month return of -4.88% contrasts with the 1-year figure, indicating recent volatility. The current price of $119.82 sits at 52.1% of its 52-week range. Short-term movements show a 1-day decline of -0.25% and a 1-week gain of +0.14%.

With a beta of 1.09, the fund moves slightly more than the market. Annualized volatility stands at 23.08%, which is labeled as High. The Sharpe ratio of 0.81 suggests moderate risk-adjusted returns relative to the risk taken. Maximum drawdown has reached -16.59%, highlighting potential downside severity. Liquidity is characterized by an average daily volume of 35,193 shares. These metrics collectively describe a fund with elevated volatility and moderate efficiency.

AI-generated summary based on the data on this page.

EIS Top Holdings

Holdings as of 2026-08-31 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 54.0% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how EIS's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.

Which Funds Overlap With EIS

Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with EIS's top 10 — IEMG overlaps most, holding 1 of the same companies as EIS's top 10 (3.8% of EIS's assets).

Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.

Market Backdrop

10-Year Treasury Yield: 4.96% (as of 2026-10-22) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.

CBOE Volatility Index (VIX): 19.03 (as of 2026-10-22) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.

Federal Funds Rate: 3.75% (as of 2026-09-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.

EIS Liquidity, Domicile & Tax Treatment

Liquidity: Average daily volume is 35K/day. Higher volume and a larger fund generally mean lower round-trip trading costs. AUM of $874M provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.

Domicile & tax treatment: EIS is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.

EIS Performance History

How EIS Compares to Other Single Country - Developed ETFs